1. Home
  2. ELTX vs PSNL Comparison

ELTX vs PSNL Comparison

Compare ELTX & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • PSNL
  • Stock Information
  • Founded
  • ELTX 2011
  • PSNL 2011
  • Country
  • ELTX United States
  • PSNL United States
  • Employees
  • ELTX N/A
  • PSNL N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • PSNL Medical Specialities
  • Sector
  • ELTX Health Care
  • PSNL Health Care
  • Exchange
  • ELTX Nasdaq
  • PSNL Nasdaq
  • Market Cap
  • ELTX 121.7M
  • PSNL 580.3M
  • IPO Year
  • ELTX N/A
  • PSNL 2019
  • Fundamental
  • Price
  • ELTX $9.20
  • PSNL $6.31
  • Analyst Decision
  • ELTX Strong Buy
  • PSNL Strong Buy
  • Analyst Count
  • ELTX 2
  • PSNL 5
  • Target Price
  • ELTX $9.50
  • PSNL $8.00
  • AVG Volume (30 Days)
  • ELTX 47.4K
  • PSNL 1.8M
  • Earning Date
  • ELTX 08-12-2025
  • PSNL 08-06-2025
  • Dividend Yield
  • ELTX N/A
  • PSNL N/A
  • EPS Growth
  • ELTX N/A
  • PSNL N/A
  • EPS
  • ELTX N/A
  • PSNL N/A
  • Revenue
  • ELTX N/A
  • PSNL $85,694,000.00
  • Revenue This Year
  • ELTX N/A
  • PSNL $0.45
  • Revenue Next Year
  • ELTX N/A
  • PSNL $25.75
  • P/E Ratio
  • ELTX N/A
  • PSNL N/A
  • Revenue Growth
  • ELTX N/A
  • PSNL 15.57
  • 52 Week Low
  • ELTX $3.70
  • PSNL $1.61
  • 52 Week High
  • ELTX $9.99
  • PSNL $7.79
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 68.72
  • PSNL 50.64
  • Support Level
  • ELTX $7.97
  • PSNL $6.52
  • Resistance Level
  • ELTX $8.94
  • PSNL $7.32
  • Average True Range (ATR)
  • ELTX 0.41
  • PSNL 0.52
  • MACD
  • ELTX 0.03
  • PSNL -0.11
  • Stochastic Oscillator
  • ELTX 96.74
  • PSNL 22.72

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: